Literature DB >> 16731921

Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M.

Andrea D Lipińska1, Danijela Koppers-Lalic, Michał Rychłowski, Pieter Admiraal, Frans A M Rijsewijk, Krystyna Bieńkowska-Szewczyk, Emmanuel J H J Wiertz.   

Abstract

Bovine herpesvirus 1 (BHV-1) interferes with peptide translocation by the transporter associated with antigen processing (TAP). Recently, the UL49.5 gene product of BHV-1 was identified as the protein responsible for the observed inhibition of TAP. In BHV-1-infected cells and virions, the UL49.5 protein forms a complex with glycoprotein M (gM). Hence, it was investigated whether UL49.5 can combine the interactions with gM and the TAP complex. In cell lines constitutively expressing both UL49.5 and gM, UL49.5 appears to be required for functional processing of gM. Immunofluorescence-confocal laser scanning microscopy demonstrated that both proteins are interdependent for their redistribution from the endoplasmic reticulum to the trans-Golgi network. Remarkably, expression of cloned gM results in the abrogation of the UL49.5-mediated inhibition of TAP and prevents the degradation of the transporter. However, in BHV-1-infected cells, differences in UL49.5 and gM expression kinetics were seen to create a window of opportunity at the early stages of infection, during which time the UL49.5 protein can act on TAP without gM interference. Moreover, in later periods, non-gM-associated UL49.5 can be detected in addition to the UL49.5/gM complex. Thus, it has been deduced that different functions of UL49.5, editing of gM processing and inhibition of TAP, can be combined during BHV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731921      PMCID: PMC1472560          DOI: 10.1128/JVI.02707-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes.

Authors:  P Cresswell
Journal:  Traffic       Date:  2000-04       Impact factor: 6.215

2.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Glycoprotein M of bovine herpesvirus 1 (BHV-1) is nonessential for replication in cell culture and is involved in inhibition of bovine respiratory syncytial virus F protein induced syncytium formation in recombinant BHV-1 infected cells.

Authors:  Patricia König; Katrin Giesow; Günther M Keil
Journal:  Vet Microbiol       Date:  2002-04-22       Impact factor: 3.293

4.  Equine herpesvirus 1 (EHV-1) glycoprotein M: effect of deletions of transmembrane domains.

Authors:  C Seyboldt; H Granzow; N Osterrieder
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

5.  The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1.

Authors:  Danijela Koppers-Lalic; Frans A M Rijsewijk; Sylvia B E Verschuren; Jacqueline A M van Gaans-van den Brink; Anne Neisig; Maaike E Ressing; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

6.  Pseudorabies virus glycoprotein M inhibits membrane fusion.

Authors:  B G Klupp; R Nixdorf; T C Mettenleiter
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M.

Authors:  Jens Rudolph; Christian Seyboldt; Harald Granzow; Nikolaus Osterrieder
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 8.  Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis--state of the art, June 1999.

Authors:  T C Mettenleiter
Journal:  Vet Res       Date:  2000 Jan-Feb       Impact factor: 3.683

9.  MHC class I ubiquitination by a viral PHD/LAP finger protein.

Authors:  J M Boname; P G Stevenson
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

10.  Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6.

Authors:  C Kyritsis; S Gorbulev; S Hutschenreiter; K Pawlitschko; R Abele; R Tampé
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

View more
  21 in total

Review 1.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

2.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.

Authors:  Anabel S de la Garza-Rodea; Marieke C Verweij; Hester Boersma; Ietje van der Velde-van Dijke; Antoine A F de Vries; Rob C Hoeben; Dirk W van Bekkum; Emmanuel J H J Wiertz; Shoshan Knaän-Shanzer
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

4.  The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.

Authors:  Marieke C Verweij; Andrea D Lipinska; Danijela Koppers-Lalic; Wouter F van Leeuwen; Jeffrey I Cohen; Paul R Kinchington; Ilhem Messaoudi; Krystyna Bienkowska-Szewczyk; Maaike E Ressing; Frans A M Rijsewijk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

5.  Herpes simplex virus 1 gN partners with gM to modulate the viral fusion machinery.

Authors:  Imane El Kasmi; Roger Lippé
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 6.  Targeted degradation of ABC transporters in health and disease.

Authors:  Daphne Nikles; Robert Tampé
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

7.  Early, active, and specific localization of herpes simplex virus type 1 gM to nuclear membranes.

Authors:  Jie Zhang; Claus-Henning Nagel; Beate Sodeik; Roger Lippé
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

8.  Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.

Authors:  Gillian E Dugan; Eric W Hewitt
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

9.  Regulation of Innate Immune Responses by Bovine Herpesvirus 1 and Infected Cell Protein 0 (bICP0).

Authors:  Clinton Jones
Journal:  Viruses       Date:  2009-09-07       Impact factor: 5.048

Review 10.  Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity.

Authors:  Martin Rowe; Jianmin Zuo
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.